Biotechnologia Acta

...

  • Increase font size
  • Default font size
  • Decrease font size
Home Archive 2019 № 1 DIAGNOSTIC CHARACTERISTICS OF THE ELISA TEST FOR THE HEPATITIS B VIRUS SURFACE ANTIGEN DETECTION E. K.Kiseleva, L. A. Ganova, E. N.Chumak, T. Yu. Trokhymchuk, V. G. Serdyuk, N. Ya. Spivak
Print PDF

ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)

"Biotechnologia Acta" V. 12, No 1, 2019
https://doi.org/10.15407/biotech12.01.058  
Р. 58-65, Bibliography 64, English
Universal Decimal Classification: 616-097.9.578

DIAGNOSTIC CHARACTERISTICS OF THE ELISA TEST FOR THE HEPATITIS B VIRUS SURFACE ANTIGEN DETECTION

E. K.Kiseleva1, L. A. Ganova2, E. N.Chumak1, T. Yu. Trokhymchuk1, V. G. Serdyuk1,
N. Ya. Spivak
1, 2

1PJSC “SPC” Diaproph-Med “, Kyiv, Ukraine
2Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine, Kyiv

The aim of the work was to define the diagnostic ability of the enzyme immunoassay test system DIAHBsAg (PJSC “SPC “Diaprof-Med””), in which the principle of analysis is based on biotin-streptavidin amplification of a specific signal.

The assay performance was studied on WHO Second International Standard for HBsAg, subtype adw2, genotype A (NIBSC code: 00/588) in concentration 0.006 IU/ml; on Capricorn HBsAg standard subtypes ad and ay in concentration 0.006 ng/ml and 0.004 ng/ml respectively. All 14 members of the HBsAg Low Titer Performance Panel PHA 106 (BBI, USA) were detected in DIA-HBsAg with high OD/CO ratio 11.9–40.7.

The DIA-HBsAg sensitivity is similar to the sensitivity of Roche COBAS and Murex HBsAg 3.0 when tested on the HBsAg Mixed Titer Performance Panel PHA 206 (BBI, USA) which consists of sera with various HBsAg concentrations.

The DIA-HBsAg has correctly detected low reactive members of the HBsAg Verification Panel VHA 601 (BBI, USA) with OD/CO ratio 21.0–40.7 whereas the negative member OD/CO was 0.4.

In the evaluation of 174 cross-reactive serum specimens one false positive result was obtained out of 8 sera reactive for IgM to HSV-1/2. The DIA-HBsAg specificity on 1 177 blood donors` specimens was 99.9%.

Key words: ELISA, diagnostics, hepatitis B, analytical and diagnostic sensitivity, specificity.

© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2019

  • References
    • 1. Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol. J. 2018, 28 (12), 26–32. https://doi.org/10.2174/1874357901812010026

      2. Gepatit B. http://www.who.int/ru/news-room/fact-sheets//hepatitis-b (In Russian).

      3. Gong D. Y., Chen E. Q., Huang F. J., Leng X. H., Cheng X., Tang H. Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivoViruses. 2013, 5 (5), 1261–1271. https://doi.org/10.3390/v5051261

      4. Global hepatitis report 2017. http://www.who.int/hepatitis/publications/global-hepatitis-report.2017/en/.

      5. Hirzel C., Pfister S., Gorgievski-Hrisoho M., Wandeler G., Zuercher S. Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samples. J. Clin. Virol. 2015, 33 (5). https://doi.org/10.1016/j.jcv.2015.05.024

      6. Li M., Xi H., Wang Q., Hou F., Huo N., Zhang X., Li F., Xu X. Kinetics of serum HBsAg in Chinese patients with chronic HBV infection with long-term adefovir dipivoxil treatment. Chin. Med. J. 2014, 127 (11), 2101–2104.

      7. Stasi S., Silvestri C., Berni R., Brunetto M. R., Zignego A. L., Orsini C., Milani S., Ricciardi L., De Luca A., Blanc P., Nencioni C., Aquilini D., Bartoloni A., Bresci G., Marchi S., Filipponi F., Colombatto P., Forte P., Galli A., Luchi S., Chigiotti S., Nerli A., Corti G., Sacco R., Car rai P., Ricchiuti A., Giusti M., Almi P., Cozzi A., Carloppi S., Laffi G., Voller F., Cipriani F. Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study. World J. Hepatol. 2018, 10 (5), 409–416. https://doi.org/10.4254/wjh.v10.i5.409

      8. Shil N., Rahman A., Sultana N., Yasmin F. Markers of hepatitis viruses by ELISA among healthy blood donors. Mymensingh. Med. J. 2015, 24 (4), 776–779.

      9. Hepatitis B and C Testing Guide, World Health Organization, 2017. http://apps.who.int//iris/ bitstream/ handle/10665/260130/9789244549988-rus.pdf. (In Russian).

      10. Hon J., Ren J., Song L., Zhao F., Liang P. Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer. J. Clin. Lab. Anal. 2018, 32 (1). https://doi.org/10.1002/jcla.22159

      11. Mostovich L. A., Bezuglova L. V., Jaroslavceva O. A., Faranosova O. N., Netesova I. G. HBsAg serovariants and the evolution of tests to identify it. http://www.fadlab.ru/.../mostovich-la-serovarianty-hbsag-22-okt-2015-khmao.pd. (In Russian).


 

Additional menu

Site search

Site navigation

Home Archive 2019 № 1 DIAGNOSTIC CHARACTERISTICS OF THE ELISA TEST FOR THE HEPATITIS B VIRUS SURFACE ANTIGEN DETECTION E. K.Kiseleva, L. A. Ganova, E. N.Chumak, T. Yu. Trokhymchuk, V. G. Serdyuk, N. Ya. Spivak

Invitation to cooperation

Dear colleagues, we invite you to publish your articles in our journal.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2008.
All rights are reserved. Complete or partial reprint of the journal is possible only with the written permission of the publisher.
E-mail
for information: biotech@biochem.kiev.ua.